# Vitreous Level Of Tumor Necrosis Factor Alpha In Patients With Retinal Vein Occlusion

> **NCT05532475** · — · COMPLETED · sponsor: **Kasr El Aini Hospital** · enrollment: 40 (actual)

## Conditions studied

- Retinal Vein Occlusion

## Interventions

- **DIAGNOSTIC_TEST:** measurement of vitreous level of tumor necrosis factor alpha

## Key facts

- **NCT ID:** NCT05532475
- **Lead sponsor:** Kasr El Aini Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-12
- **Primary completion:** 2022-10-20
- **Final completion:** 2022-10-30
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2024-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05532475

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05532475, "Vitreous Level Of Tumor Necrosis Factor Alpha In Patients With Retinal Vein Occlusion". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05532475. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*